|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jary M, Lecomte T, Bouché O, Kim S, Dobi
E, Queiroz L, Ghiringhelli F, Etienne H, Leger J, Godet Y, et al:
Prognostic value of baseline seric Syndecan-1 in initially
unresectable metastatic colorectal cancer patients: A simple
biological score. Int J Cancer. 139:2325–2335. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barkhatov L, Fretland AA, Kazaryan AM,
Rosok BI, Brudvik KW, Waage A, Bjornbeth BA, Sahakyan MA and Edwin
B: Validation of clinical risk scores for laparoscopic liver
resections of colorectal liver metastases: A 10-year observed
follow-up study. J Surg Oncol. 114:757–763. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pritchard CC and Grady WM: Colorectal
cancer molecular biology moves into clinical practice. Gut.
60:116–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Simons K and Toomre D: Lipid rafts and
signal transduction. Nat Rev Mol Cell Biol. 1:31–39. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Babuke T and Tikkanen R: Dissecting the
molecular function of reggie/flotillin proteins. Eur J Cell Biol.
86:525–532. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bickel PE, Scherer PE, Schnitzer JE, Oh P,
Lisanti MP and Lodish HF: Flotillin and epidermal surface antigen
define a new family of caveolae-associated integral membrane
proteins. J Biol Chem. 272:13793–13802. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Banning A, Tomasovic A and Tikkanen R:
Functional aspects of membrane association of reggie/flotillin
proteins. Curr Protein Pept Sci. 12:725–735. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lang DM, Lommel S, Jung M, Ankerhold R,
Petrausch B, Laessing U, Wiechers MF, Plattner H and Stuermer CA:
Identification of reggie-1 and reggie-2 as
plasmamembrane-associated proteins which cocluster with activated
GPI-anchored cell adhesion molecules in non-caveolar micropatches
in neurons. J Neurobiol. 37:502–523. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Langhorst MF, Reuter A and Stuermer CA:
Scaffolding microdomains and beyond: The function of
reggie/flotillin proteins. Cell Mol Life Sci. 62:2228–2240. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schulte T, Paschke KA, Laessing U,
Lottspeich F and Stuermer CA: Reggie-1 and reggie-2, two cell
surface proteins expressed by retinal ganglion cells during axon
regeneration. Development. 124:577–587. 1997.PubMed/NCBI
|
|
13
|
Stuermer CA, Lang DM, Kirsch F, Wiechers
M, Deininger SO and Plattner H: Glycosylphosphatidyl
inositol-anchored proteins and fyn kinase assemble in noncaveolar
plasma membrane microdomains defined by reggie-1 and −2. Mol Biol
Cell. 12:3031–3045. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hazarika P, McCarty MF, Prieto VG, George
S, Babu D, Koul D, Bar-Eli M and Duvic M: Up-regulation of
Flotillin-2 is associated with melanoma progression and modulates
expression of the thrombin receptor protease activated receptor 1.
Cancer Res. 64:7361–7369. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Berger T, Ueda T, Arpaia E, Chio II,
Shirdel EA, Jurisica I, Hamada K, You-Ten A, Haight J, Wakeham A,
et al: Flotillin-2 deficiency leads to reduced lung metastases in a
mouse breast cancer model. Oncogene. 32:4989–4994. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang X, Yang Q, Guo L, Li XH, Zhao XH,
Song LB and Lin HX: Flotillin-2 is associated with breast cancer
progression and poor survival outcomes. J Transl Med. 11:1902013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee KW, Lee SS, Kim SB, Sohn BH, Lee HS,
Jang HJ, Park YY, Kopetz S, Kim SS, Oh SC and Lee JS: Significant
association of oncogene YAP1 with poor prognosis and cetuximab
resistance in colorectal cancer patients. Clin Cancer Res.
21:357–364. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun L, Hu S, Yu L, Guo C, Sun L, Yang Z,
Qi J and Ran Y: Serum haptoglobin as a novel molecular biomarker
predicting colorectal cancer hepatic metastasis. Int J Cancer.
138:2724–2731. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao K, Xie D, Cao P, Zou Q, Lu C, Xiao S,
Zhou J and Peng X: SiRNA-mediated flotillin-2 (Flot2)
downregulation inhibits cell proliferation, migration, and invasion
in gastric carcinoma cells. Oncol Res. 21:271–279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Lin L, Huang Z, Ji B, Mei S, Lin Y
and Shen Z: High expression of flotillin-2 is associated with poor
clinical survival in cervical carcinoma. Int J Clin Exp Pathol.
8:622–628. 2015.PubMed/NCBI
|
|
23
|
Wang YL, Yao WJ, Guo L, Xi HF, Li SY and
Wang ZM: Expression of flotillin-2 in human non-small cell lung
cancer and its correlation with tumor progression and patient
survival. Int J Clin Exp Pathol. 8:601–607. 2015.PubMed/NCBI
|
|
24
|
Zhao L, Lin L, Pan C, Shi M, Liao Y, Bin J
and Liao W: Flotillin-2 promotes nasopharyngeal carcinoma
metastasis and is necessary for the epithelial-mesenchymal
transition induced by transforming growth factor-β. Oncotarget.
6:9781–9793. 2015.PubMed/NCBI
|
